00:30 · 20 āļžāļĪāļĐāļ āļēāļ„āļĄ 2023

Catalent gaining over 12% after investor call 🚀

Catalent (CTLT.US) is rising as much as 12% to $36.3 after the company assured investors that its challenges are temporary, while formally cutting its full-year guidance during the much-delayed investor call.

Catalent is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies, and consumer health products. Company slashed fiscal full-year outlook and delayed quarterly earnings report announcing that adjusted EBITDA would be in the range of $725 million to $775 million, down from the earlier projection of $1.22 billion to $1.3 billion. CEO Alessandro Maselli acknowledged that the company had been overly optimistic about annual growth and had failed to reduce costs promptly after rapid expansion during the pandemic. Despite remaining the worst performer among S&P 500 healthcare stocks in May, Catalent's shares are gaining significantly today.

The challenges faced by Catalent, including compliance issues and lower biotech funding, have impacted its financial performance. The company received a notice of non-compliance with listing requirements from the New York Stock Exchange due to a delayed filing. Catalent is still working on completing its fiscal Q3 report. Furthermore, the company's growth prospects have been shaken, with declining takeover interest. The recent events have caused investor sentiment to reach an all-time low, with doubts about the company's operational and forecasting capabilities.

Catalent stock price (CTLT.US), D1, source: xStation 5

āļĢāļąāļš Welcome Bonus 10% āđ€āļĄāļ·āđˆāļ­āđ€āļĢāļīāđˆāļĄāđ€āļ—āļĢāļ”āļāļąāļš XTB

āļĢāļąāļš Welcome Bonus 10% āđ€āļĄāļ·āđˆāļ­āđ€āļĢāļīāđˆāļĄāđ€āļ—āļĢāļ”āļāļąāļš XTB

āđ€āļĢāļīāđˆāļĄāļ•āđ‰āļ™āļ‡āđˆāļēāļĒ āđ† āđ€āļžāļĩāļĒāļ‡āđ€āļ›āļīāļ”āļšāļąāļāļŠāļĩāđāļĨāļ°āļāļēāļāđ€āļ‡āļīāļ™āļ„āļĢāļąāđ‰āļ‡āđāļĢāļ āļāđ‡āļĢāļąāļšāđ‚āļšāļ™āļąāļŠāļŠāļđāļ‡āļŠāļļāļ” 10 USD āđ€āļ‚āđ‰āļēāļšāļąāļāļŠāļĩāđ€āļ—āļĢāļ”āļ‚āļ­āļ‡āļ„āļļāļ“āđ‚āļ”āļĒāļ•āļĢāļ‡ āļžāļĢāđ‰āļ­āļĄāđ€āļ—āļĢāļ” āļŸāļ­āđ€āļĢāđ‡āļāļ‹āđŒ āļ—āļ­āļ‡āļ„āļģ āļ”āļąāļŠāļ™āļĩāđāļĨāļ°āļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāļ­āļ·āđˆāļ™ āđ†Â āļ­āļĩāļāļĄāļēāļāļĄāļēāļĒ 

āļĢāļąāļšāđ‚āļšāļ™āļąāļŠ 10% āļĢāļąāļšāđ‚āļšāļ™āļąāļŠ 10% āļĢāļąāļšāđ‚āļšāļ™āļąāļŠ 10% āļĢāļąāļšāđ‚āļšāļ™āļąāļŠ 10%
20 āļžāļĪāļĻāļˆāļīāļāļēāļĒāļ™ 2026, 22:57

Wall Street āļĢāđˆāļ§āļ‡āļŦāļ™āļąāļāđ€āļ›āđ‡āļ™āļŠāļĩāđāļ”āļ‡

20 āļžāļĪāļĻāļˆāļīāļāļēāļĒāļ™ 2026, 16:14

ECB āđ€āļ•āļ·āļ­āļ™āļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡āļŸāļ­āļ‡āļŠāļšāļđāđˆ AI āļˆāļēāļāļāļĢāļ°āđāļŠ IPO āđāļĨāļ°āļŦāļ™āļĩāđ‰āļĄāļŦāļēāļĻāļēāļĨāļ‚āļ­āļ‡ Big Tech

20 āļžāļĪāļĻāļˆāļīāļāļēāļĒāļ™ 2026, 14:03

āļ”āļąāļŠāļ™āļĩāļŦāļļāđ‰āļ™āđāļĨāļ°āđ‚āļĨāļŦāļ°āļĒāļąāļ‡āļ„āļ‡āļ›āļĢāļąāļšāļ•āļąāļ§āļĨāļ”āļĨāļ‡ ðŸ“‰

20 āļžāļĪāļĻāļˆāļīāļāļēāļĒāļ™ 2026, 09:04

Anthropic āđ€āļ›āļīāļ”āļ•āļĨāļēāļ”āđāļĢāļ‡ āđāļ•āđˆāļāļ§āđˆāļēāļˆāļ°āļ›āļīāļ”āļ§āļąāļ™ āļŠāđˆāļ§āļ™āļ•āđˆāļēāļ‡āļŦāļēāļĒāđ„āļ›āļ„āļĢāļķāđˆāļ‡āļŦāļ™āļķāđˆāļ‡ āđāļĨāļ°āļ•āļĨāļēāļ”āļ—āļąāđ‰āļ‡āļāļĢāļ°āļ”āļēāļ™āļāđ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāđˆāļ§āļ‡āļ‰āļĨāļ­āļ‡āļ”āđ‰āļ§āļĒ

āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ—āļĩāđˆāđ€āļĢāļēāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļĄāļĩāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡ āđ€āļĻāļĐāļŦāļļāđ‰āļ™ (Fractional Shares) āđ€āļ›āđ‡āļ™āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļĩāđˆāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļˆāļēāļ XTB āđāļŠāļ”āļ‡āļ–āļķāļ‡āļāļēāļĢāđ€āļ›āđ‡āļ™āđ€āļˆāđ‰āļēāļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļšāļēāļ‡āļŠāđˆāļ§āļ™āļŦāļĢāļ·āļ­ ETF āđ€āļĻāļĐāļŦāļļāđ‰āļ™āđ„āļĄāđˆāđƒāļŠāđˆāļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ­āļīāļŠāļĢāļ° āļŠāļīāļ—āļ˜āļīāļ‚āļ­āļ‡āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ­āļēāļˆāļ–āļđāļāļˆāļģāļāļąāļ”
āļ„āļ§āļēāļĄāļŠāļđāļāđ€āļŠāļĩāļĒāļŠāļēāļĄāļēāļĢāļ–āđ€āļāļīāļ™āļāļ§āđˆāļēāđ€āļ‡āļīāļ™āļ—āļĩāđˆāļāļēāļ